{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T15:13:57Z","timestamp":1781968437354,"version":"3.54.5"},"reference-count":19,"publisher":"Informa Healthcare","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.3111\/13696990903149479","type":"journal-article","created":{"date-parts":[[2009,7,17]],"date-time":"2009-07-17T06:11:37Z","timestamp":1247811097000},"page":"164-169","source":"Crossref","is-referenced-by-count":15,"title":["Costs of haematological adverse events in chronic myeloid leukaemia patients: a retrospective cost analysis of the treatment of anaemia, neutropenia and thrombocytopenia in patients with chronic myeloid leukaemia"],"prefix":"10.3111","volume":"12","author":[{"given":"Clazien","family":"Bouwmans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Huijgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carin","family":"Uyl-de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2009,7,17]]},"reference":[{"key":"CIT0001","first-page":"1497","volume":"132","author":"Nowell","year":"1960","journal-title":"Science"},{"issue":"8","key":"CIT0002","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1172\/JCI31771","volume":"117","author":"Nowell","year":"2007","journal-title":"J Clin Invest"},{"issue":"5940","key":"CIT0003","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/306239a0","volume":"306","author":"Heisterkamp","year":"1983","journal-title":"Nature"},{"issue":"5940","key":"CIT0004","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/306277a0","volume":"306","author":"Bartram","year":"1983","journal-title":"Nature"},{"issue":"17","key":"CIT0005","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","volume":"340","author":"Sawyers","year":"1999","journal-title":"N Engl J Med"},{"issue":"11","key":"CIT0006","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","volume":"348","author":"O'Brien","year":"2003","journal-title":"N Engl J Med"},{"issue":"14","key":"CIT0008","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"issue":"23","key":"CIT0009","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"Druker","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"CIT0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00044011-200727060-00002","volume":"27","author":"Liou","year":"2007","journal-title":"Clin Drug Invest"},{"key":"CIT0012","unstructured":"van Loenen A. (ed.) Farmacotherapeutisch Kompas. [ Pharmacotherapeutic Compass] (in Dutch). Houten: Bohn Stafleu van Loghum, 2003"},{"key":"CIT0014","first-page":"37","volume":"11","author":"Uyl-de Groot","year":"2005","journal-title":"Eur J Hosp Pharm Sci"},{"issue":"7","key":"CIT0016","first-page":"2177","volume":"8","author":"Kantarjian","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"7","key":"CIT0017","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1182\/blood-2004-02-0711","volume":"104","author":"Kantarjian","year":"2004","journal-title":"Blood"},{"issue":"3","key":"CIT0019","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s10198-002-0112-y","volume":"3","author":"Herold","year":"2002","journal-title":"Eur J Health Econ"},{"issue":"6","key":"CIT0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00001813-199907000-00013","volume":"10","author":"Annemans","year":"1999","journal-title":"Anticancer Drugs"},{"issue":"5","key":"CIT0021","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1634\/theoncologist.6-5-441","volume":"6","author":"Calhoun","year":"2001","journal-title":"Oncologist"},{"issue":"12","key":"CIT0022","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1002\/cncr.11447","volume":"97","author":"Cantor","year":"2003","journal-title":"Cancer"},{"issue":"6","key":"CIT0023","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/cncr.11195","volume":"97","author":"Elting","year":"2003","journal-title":"Cancer"},{"key":"CIT0024","author":"Malone","year":"1995","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3111\/13696990903149479","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,18]],"date-time":"2017-06-18T18:00:53Z","timestamp":1497808853000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.3111\/13696990903149479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,5,7]]},"published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.3111\/13696990903149479"],"URL":"https:\/\/doi.org\/10.3111\/13696990903149479","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}